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Abstract 
Long-term use of opioids has acute effects on homeostasis of the 
body. Discovering the impacts of opioids on hematological parameters 
of narcotics withdrawal and dependents blood may be helpful in 
recognizing the homeostasis condition of their body for the useful 
treatment. 
Background: 
In this study a cross-sectional method was applied. The abusers of 
opium and heroin for more than two consecutive years were considered 
as opium and heroin dependent groups, respectively. The dependent 
people, who passed the 1-month withdrawal period, entered the study as 
opium and heroin withdrawal groups. In this study, hematological 
factors of heroin and opium dependent and withdrawal groups were 
investigated. 
Methods: 
The RBC count remained unchanged in all groups. The WBC count 
had a significant increase in opium dependent group but in heroin 
dependent group and withdrawal group there was no significant 
difference. HGB level had a significant increase only in opium and 
heroin withdrawal groups. The percentage of HCT had a significant 
increase in all groups. The MCV increased in heroin and opium 
dependent groups. MCH level increased significantly in heroin and 
opium withdrawal groups. MCHC level had a significant increase in 
all groups. Neutrophil and lymphocyte counts in heroin and opium 
addicted groups significantly decreased. Platelet, neutrophil and 
monocyte counts significantly increased in opium dependent group. 
Monocyte countshowed a significant reduction in heroin withdrawal 
group. Eosinophil count showed no difference in any of the groups. 
Findings: 
The current study indicated that not only the chronic and long-term 
use of opium and heroin, also withdrawal of addicted people could 
change hematological parameters related to human serum. 
Conclusion: 
Hematological factors, Serum, Addiction, Addiction withdrawal, 
Heroin, Iran. 
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Introduction  
Addiction is an increasing issue in all over the 
world. Since heroin and cocaine abuse in western 
societies are mostly from opioid compounds, 
most of these countries researches are focused on 
these two drugs. In Iran, among the opioid 
compounds, opium has the highest consumption; 
besides, Iran is the first consumer of the opium in 
all over the world.1 The opium which is extracted 
from the juice of poppy capsules (papaver 
somniferum)2 is used as the raw material for the 
synthesis of some medications such as morphine, 
noscapine and papaverine (10%, 6% and 1% of 
opium, respectively).3 The effects of opium are 
mostly from its morphine, but unexpected 
intoxications and diseases such as esophageal 
cancer in abusers of “dross opium” and 
polyneuropathy due to addition of arsenics in 
impurities occurred.2 Also, since more than 20 
alkaloids4 and more than 70 ingredients are 
present in opium,5 its impacts can be different in 
comparison with pure morphine, noscapine and 
papaverine. Heroin is the very methyl-D-
morphine. Heroin may affect the immune system 
either directly on opioid receptors, lymphocytes 
and macrophages6,7 or indirectly through 
effecting on nervous system of the immune 
system.8 Many studies have shown that 
consuming opiates have acute and chronic effects 
on different body systems. Using narcotics 
including opium and heroin would lead to 
changes in body electrolytes,9 electrophoretic 
profile of serum proteins,10,11 and coagulation 
factors.12 Also, it would inhibithypothalamus-
pituitary-gonadal axis13 and consequently reduce 
the levels of gonadal hormones including 
testosterone, serum LH, FSH and PTH.14-16 
Moreover, it was indicated that red and white 
blood cell counts, hemoglobin, hematocrit and 
platelets level of the opium dependents did not 
change.17 In heroin dependent and withdrawal 
groups, some changes in immune function and 
blood lymphocytes occurred.18 Some other 
studies also indicated that consumption of 
opioids may cause cofactor role in dependent 
people for infectious diseases.19,20 However, many 
studies have been done on the effect of acute and 
chronic opioids compounds on the immune 
system,19,21 but withdrawing of drugs such as 
morphine and heroin also might have important 
effects on the immune system in narcotic 
dependent patients.22 Therefore, it is very 
important to discover the main aspect of blood 
toxicology, especially in drug dependent people 
and especially after the withdrawal period. 
Consequently, suitable, efficient and preventive 
treatments should be used in order to reduce the 
contingent side effects. So far, in previous studies 
about narcotic effects especially opium which has 
the highest rate of narcotic abuse in Iran-,1 no 
comprehensive study has been done yet on 
hematological parameters of heroin and 
morphine dependents in comparison with such 
parameters of withdrawal people. In this study, 
we tried to review the effect of narcotic addiction 
(heroin and opium) on hematological parameters 
of dependent people in their addiction and 
withdrawal period in order to create a base for 
further studies of the researchers about 
fundamental studies of narcotics, prevention, 
etiology and particularly its treatments. 
 
Methods 
TIn this study, a cross-sectional method was 
applied. The subjects included 180 males between 
25 to 45 year-old, addicted to opium and heroin 
referred to the medical center for a 3-month 
withdrawal period. Those who were the abusers 
of opium (smoking, inhaling and opium pipe 
method) and heroin (inhaling method) were 
considered as opium dependent and heroin 
dependent groups, respectively. The subjects of 
these groups were considered in withdrawal 
group if they stopped the drug abuse (opium and 
heroin) for one month. Some of the non-addicted 
volunteers, who were in compliance with this 
population in terms of age, were selected as the 
control group. According to DSM-IV criteria, only 
the opium and heroin dependent people were 
allowed to enter the study. The individuals who 
abused several drugs simultaneously and other 
abusers as substance abusers, recreational abusers 
and trial abusers were excluded. The test subjects 
who already suffered from syphilis, hepatitis, 
AIDS or any infectious disease with detectable 
clinical signs such as skin diseases also were 
excluded. In order to ensure about continuous 
abuse of opioids compound, urine sample for 
diagnostic specimens were obtained from 
individuals who were considered as opioid-
dependents. At the beginning, one screening test 
(rapid immunochromatographic test) was 
conducted on the samples. Thereafter, in order to 
approve opium and heroin abuse, solid-liquid 
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column chromatography test and then, thin layer 
chromatography was conducted on positive cases 
of screening (Baharafshan, Tehran, Iran). In order 
to ensure that control and withdrawal groups did 
not use any opioids drugs, experiment 
investigation of opioids compounds was 
conducted on the urine of mentioned individuals 
(only RSA was done using rapid 
immunochromatographic technique). First, the 
aim of this study was explained to the test 
subjects. Then, regarding to anonymity, consent 
form was obtained consciously before blood and 
urine sampling. Meanwhile, this research was 
approved by Ethics Committee of Kerman 
Neuroscience Research Center at Kerman 
University of Medical Sciences by moral code 
number EC/KNRC/88-31. Demographic data 
about the age, type of drug, last date of 
consumption and duration of addiction were 
collected. Given a special code to each individual, 
hematological parameters were obtained by 
trusted researchers. In order to determine 
hematological parameters, the following stages 
were carried out: 2 ml fresh venous blood was 
collected in test tubes containing specific EDTA 
anticoagulant, and then the following tests were 
carried out on the samples utilizing Coulter 
Counter Sysmex: complete blood cell count (CBC) 
for red and white blood cell, hemoglobin level 
(HGB), hematocrit percentage (HCT) and 
calculating cell indices including mean 
corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), differential 
leukocyte count (lymphocytes, monocytes, 
basophiles, eosinophils) and blood platelets. 
 
Statistical analysis  
The data were analyzed by SPSS11.5 software and 
presented in mean (standard deviation). 
Parametric test was also used for comparison 
between the groups. Moreover, the significant 
level of 0.05 was considered. 
 
Results 
The comparison of hematological factors in 
opium dependent and opium withdrawal groups 
One-way ANOVA indicated that in the period of 
opium dependence and its related withdrawal, 
red blood cell count remained unchanged both 
toward each other and in comparison with that 
in the control group. The white blood cell count 
actually had a significant increase in comparison 
with that in control group (P < 0.05), but in the 
subsequent withdrawal group it showed a non-
significant decrease. The platelet, neutrophil and 
monocyte counts were significantly increased in 
opium dependents (P < 0.01, P < 0.001, and  
P < 0.05 respectively). In the opium withdrawal 
group, the number of platelets, neutrophils and 
monocytes were decreased in comparison with 
those in addiction period and the reduction in 
neutrophil count was significant (P < 0.001). The 
lymphocyte count had a significant reduction in 
opium dependent group (P < 0.001) and had 
reached to the level of that in control group. In 
opium dependence and subsequent withdrawal 
period, the number of eosinophils (EOS) showed 
no difference toward each other and in 
comparison with that in control group. The level 
of hematocrit in opium dependence and 
subsequent withdrawal group was significantly 
increased (P < 0.001) in comparison with that in 
control group; however in subsequent 
withdrawal group there was no significant 
difference. The hemoglobin and MCH level in 
opium dependent group had no difference in 
comparison with those in control group but, in 
subsequent withdrawal group, the HGB and 
MCH level had a significant increase both in 
comparison with those in dependency period  
(P < 0.001) and control group (P < 0.001). The 
mean corpuscular volume (MCV) in opium 
dependent group also had a significant increase 
in comparison with that in control group  
(P < 0.05). Although in withdrawal period, the 
MCV increased compared to that in control 
group, but the increase was not significant. The 
MCHC significantly decreased in opium 
dependent group in comparison with that in 
control group (P < 0.001) but in subsequent 
withdrawal opium group, it showed a 
significant increase in comparison to that both in 
dependent and control groups (P < 0.001).  
 
The comparison of hematological factors in 
heroin dependent and heroin withdrawal groups 
One-way ANOVA indicated that in heroin 
dependence and heroin withdrawal periods, red 
blood cell count did not change toward each 
other and in comparison with that in the control 
group. The white blood cell count in heroin 
dependent group and heroin withdrawal group 
had a non-significant difference toward that in 
the control group. The platelet and neutrophil 
counts in heroin dependents increased; this 
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increase in neutrophils was significant toward 
that in control group (P < 0.01). In subsequent 
heroin withdrawal, the number of platelets and 
neutrophils decreased in comparison with those 
in dependency period and this reduction was 
significant in neutrophils (P < 0.001). The 
monocyte count decreased in heroin dependent 
and withdrawal groups and this reduction was 
significant in withdrawal period in comparison 
with that in the control group (P < 0.01). The  
 
number of lymphocytes had a significant 
reduction in heroin dependent group (P < 0.01). 
The lymphocyte count in subsequent 
withdrawal period had a significant increase in 
comparison with that in dependency period  
(P < 0.001). However, no significant difference 
was seen in neutrophil count between the 
control and withdrawal groups. In heroin 
dependence and its subsequent withdrawal 
period, the number of eosinophils had no 
difference toward each other and in comparison 
with that in the control group. The hematocrit 
level in heroin dependent and subsequent 
withdrawal groups had a significant increase in 
comparison with that in the control group  
(P < 0.001), however no significant difference 
was seen in hematocrit level between heroin 
dependent and subsequent withdrawal groups. 
The hemoglobin level did not change in heroin 
dependent group in comparison with that in the 
control group but, in the subsequent 
withdrawal, the hemoglobin level had a 
significant increase in comparison with that both 
in dependency period (P < 0.05) and control 
group (P < 0.001). The MCH level in heroin 
dependent group non-significantly increased in 
comparison with that in the control group, but in 
subsequent withdrawal group it had a 
significant increase in comparison with that in 
the control group (P < 0.001). In heroin 
dependence period and its subsequent 
withdrawal period, no significant difference was 
seen in MCH level. MCH increased in heroin 
dependency period and its subsequent 
withdrawal period and this increase in heroin 
dependent group had a significant difference in 
comparison with that in control group  
(P < 0.001). The MCHC volume significantly 
decreased in heroin dependent group in 
comparison with that in the control group  
(P < 0.001). However, MCHC level in subsequent 
withdrawal group significantly increased 
compared to that both in dependent and control 
groups (P < 0.001). 
 
Table 1. Hematologic factors in control, opium dependent and opium withdrawal groups 
 
Groups 
Mean (SEM) 
Hematologic factors 
Opium Withdrawal Opium Dependent Control 
7.88 (0.34) 8.43 (0.56)* 7.33 (0.14) WBC 
5.19 (0.1) 5.1 (0.11) 5.25 (0.5) RBC 
16.34 (0.23)*** 14.19 (0.3)### 14.46 (0.15) HGB 
45.41 (0.64)*** 46.0 (0.94)*** 41.91 (0.39) HCT 
88.03 (1.08) 89.53 (1.99)* 84.7 (0.65) MCV 
31.69 (0.47)*** 27.81 (0.72)### 27.62 (0.24) MCH 
35.90 (0.22)*** 30.69 (0.35)***### 32.93 (0.92) MCHC 
253.15 (9.18) 289.1 (14.05)** 242.97 (5.27) PLT 
56.32 (1.53) 66.034 (2.3)***#### 57.78 (0.67) NEUT 
40.47 (1.56) 30.47 (2.17)***### 38.42 (0.66) LYMPH 
2.17 (0.25) 4.92 (0.21)* 2.79 (0.15) MONO 
2.31 (0.24) 2.65 (0.65) 2.68 (0.13) EOS 
 
Standard error of the mean was used in data. 
*: P < 0.05, **: P < 0.01, ***: P < 0.001 vs. Control Group, ###: P < 0.001 Opium Withdrawal vs. Opium dependent 
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Table 2. Hematologic factors in control, heroin dependent and heroin withdrawal groups 
 
Groups  
Mean (SEM) 
Hematologic factors 
Heroin Withdrawal Heroin Dependent Control 
7.38 (0.27) 8.91 (1.05) 7.33 (0.14) WBC 
5.24 (0.13) 4.99 (0.19) 5.25 (0.5) RBC 
16.54 (0.26)*** 14.75 (0.37)# 14.46 (0.15) HGB 
45.52 (0.62)*** 47.32 (1.14)*** 41.91 (0.39) HCT 
88.31 (1.41) 95.3 (2.21)*** 84.7 (0.65) MCV 
31.75 (0.66)*** 29.67 (0.72) 27.62 (0.24) MCH 
36.13 (0.29)*** 31.13 (0.34)***### 32.93 (0.92) MCHC 
246.3 (10.04) 291.14 (23.5) 242.97 (5.27) PLT 
54.19 (1.43) 68.3 (3.54)**### 57.78 (0.67) NEUT 
43.04 (1.47) 28.5 (3.28)**### 38.42 (0.66) LYMPH 
1.65 (0.17)** 1.86 (0.46) 2.79 (0.15) MONO 
2.15 (0.18) 2.43 (0.95) 2.68 (0.13) EOS 
 
Standard error of the mean was used in data. 
*: P < 0.05, **: P < 0.01, ***: P < 0.001 vs. Control Group, #: P < 0.05, Heroin Withdrawal vs. Heroin 
dependent; ###: P < 0.001 
 
Discussion 
The results showed that in opium and heroin-
dependence and withdrawal period of opioids, 
red blood cell counts had no change. White blood 
cell count however increased in opium-
dependent group but decreased in withdrawal 
group. WBC count had a non-significant increase 
in heroin dependent group, while in subsequent 
withdrawal and control group did not have any 
significant difference. In a study on morphine 
dependent dogs and their withdrawal period 
(studies in chronic morphine poisoning in dogs), 
RBC count did not change in dependency period, 
but decreased in withdrawal period. The above-
mentioned study also showed that WBC count 
had no change in dependency period but 
decreased in withdrawal period.23 The current 
study determined that lymphocyte count 
significantly decreased in opium and heroin 
dependent groups. In previous studies, opposite 
results were reported; i.e., both increase and 
decrease in peripheral lymphocyte counts of 
heroin dependent people were demonstrated. In 
another study it was indicated that in heroin 
addicted people, the total number and percentage 
of lymphocytes and T cells construction decreased 
in peripheral blood circulation.24 On the contrary, 
another report indicated that in heroin addicted 
people who had no malnutrition, T cell count 
increased in their blood.25 It also showed that the 
average number of leucocytes increased in heroin 
dependent people; however, none of them had 
any infectious disease.26 Louria (1976) reported 
leukocytosis and fever without visible symptoms 
of infectious disease in heroin addicted people.27 
Isbell (1968) and Sapira (1947) observed that 
heroin dependent people had an increase in 
leucocytes and erythrocytes sedimentation rate in 
comparison with that in the control group. These 
observations led to the conclusion that improper 
feeding, lack of self-care, inadequate diet and low 
level of hemoglobin would cause anemia and 
infection in heroin dependent group.28,29 In 
another study, the effect of 6-month heroin 
consumption was shown on some of the blood 
parameters such as reduced the lymphocyte 
percentage.30 Morphine is the agonist of µ opioids 
receptors and the main and active metabolite of 
heroin. It was indicated that morphine and heroin 
in dose dependent way could reduce the 
proliferation of lymphocytes. Moreover, these 
inhibitory effects disappeared by naloxone.18,31 
The possible mechanism of immune suppression 
by morphine might regulate the immune system 
either directly via mu opiate receptors located on 
the immune cells, or indirectly through a central 
pathway with the activity of the mu receptors in 
the central nervous system (CNS).32 Opioid 
compounds may affect CNS through HPA 
descending axis activity and sympathetic nervous 
system.33 HPA axis activity may release the 
repressive glucocorticoids on immune system, 
while increase the peripheral release of 
sympathetic activity of epinephrine, 
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norepinephrine and dopamine from the adrenal 
center. Norepinephrine and glucocorticoids both 
act as negative regulators of immune system by 
affecting the leucocytes.34, 35 The ability of immune 
system in rhesus monkeys may take two years as 
a result of morphine dependency.36 It was 
indicated that withdrawing after long-term and 
chronic use of opioids may cause 
immunosuppression. A study on the rats 
determined that morphine withdrawal after 8 
hours caused inhibition of T cells activity, 
inhibition of B cells proliferation and production 
of interleukin 2.37 Another study also showed that 
24 hours after stopping exposure to chronic 
morphine and cocaine, corticosterone plasma 
level increased and immune system was 
suppressed. Around 3 days after withdrawal, 
despite that corticosterone level reached to its 
basic level, the suppression of immune system 
still continued. Therefore, although there would 
be still some stressing effects of cocaine and 
morphine withdrawal along with HPA axis 
activity, there were still other accurate 
mechanisms in creating these long effects on the 
immune system, which are not yet identified.38 
Moreover, in the current study, one month after 
initiating withdrawal of opium and heroin, the 
number of lymphocytes had a significant increase 
compared to that in the addiction period and 
besides it reached to the control group level. 
Immune system function in heroin addicted 
people who initiated withdrawal period, 
generally reduces in 15- to 21- days and 6- to 24- 
months. But it seemed that in withdrawing 
period, immunological parameters came back to 
normal after passing 2 years.18 In a study which 
was about the effects of cocaine withdrawal on 
the immune system, it was shown that the 
proliferation of blood circulation lymphocytes 
decreased from 2 hours to 6 days after cocaine 
withdrawal.39  
In the current study, the neutrophil count 
significantly increased in opium and heroin 
dependent groups. But, in the subsequent opium 
and heroin withdrawal groups, neutrophil 
decreased compared to that in dependency 
period. The monocytes significantly increased in 
opium dependent people. But, in opium 
withdrawal group, monocytes decreased non-
significantly in comparison to that in the control 
group. The monocyte count decreased in heroin 
dependent and withdrawal period and this 
reduction was significant in comparison to that in 
the control group. In heroin and opium 
dependent and its subsequent withdrawal period, 
the number of EOS did not change toward each 
other and in comparison with that in the control 
group. Unlike the current study, in a study which 
was carried out on the monkeys in morphine 
dependent period, the total neutrophil, monocyte 
and lymphocyte counts did not change compared 
to the original level of these factors before being 
addicted; but, in withdrawal period, the total 
lymphocyte count decreased and neutrophils 
significantly increased in comparison with those 
in the addiction period.40 The difference between 
the results of mentioned studies and those of the 
current study might be due to difference in the 
type of material and method of injection, 
addiction time and the duration of withdrawal 
period. In those studies, monkeys were studied 
in-vitro and under controlled condition and their 
addiction period took 3 months. In this study, the 
animals were given oral morphine in meals. Then, 
hematological factors were assessed two weeks 
after morphine and syndrome withdrawal. In 
another study on the morphine-dependent dogs, 
the number of WBC did not change in morphine 
dependent dogs, but in withdrawal period, the 
multi-core neutrophil count increased. Naturally, 
WBC and RBC counts in dogs are higher than 
those in humans.23 There are also several reports 
which suggested after prescription of heroin and 
morphine, some parameters of immune system 
would strengthen. So that in mice it was shown 
that the production of some of the cytokines 
increased a few minutes after using morphine.41 
The other studies showed that the monocyte 
count was higher than normal level in heroin 
dependent patients.30, 42 The current study also 
indicated that HGB increased only in opium and 
heroin withdrawal groups. The HTC percentage 
significantly increased in all dependent and 
withdrawal groups. MCV level increased in 
opium and heroin dependent groups, but in 
opium and heroin withdrawal groups, this 
increase was not significant in comparison with 
those in the control group. MCH value did not 
change in opium and heroin dependent groups, 
but it significantly increased in heroin and opium 
withdrawal group. The MCHC significantly 
decreased in opium and heroin dependent groups 
in comparison with that in the control group. But 
in opium and heroin withdrawal groups, it 
increased significantly both in comparison with 
those in the relative dependent and control 
groups. Platelets count increased in opium and 
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heroin dependent groups in comparison with that 
in the control group and this increase was 
significant in opium dependent group. In opioid 
withdrawal group, no significant difference was 
observed between withdrawal and control 
groups. In another study in parallel with the 
current study it was shown that blood 
hemoglobin increased in heroin addicted people, 
but in people who used methadone, the amount 
of hemoglobin decreased to its normal level.43 On 
the other hand, six-months heroin consumption 
did not cause major changes in erythrocyte 
parameters such as RBC count and hemoglobin 
and hematocrit levels.30 It was also indicated that 
low blood platelets and hemoglobin would 
decrease in heroin dependent people.29 Another 
study which was done on morphine-dependent 
dogs showed that blood hemoglobin content did 
not change, but in withdrawal period, it 
decreased in parallel with RBC.23 Sapira also 
showed that hemoglobin concentration decreased 
in morphine dependent people.44 Also, in a 
similar observation reported by Pastone et al, it  
was indicated that hemoglobin and hematocrit 
levels decreased in heroin injection abusers.45 
Finally, it is worth mentioning that different 
parameters such as the level of education, culture, 
diet type, medicine prescription method, method 
and duration of withdrawal and its conditions 
which were very complicated and sometimes 
uncontrollable in human studies might be 
involved in such changes in opioid dependence 
period and its subsequent withdrawal. 
Nevertheless, the aim of the current study was to 
facilitate new ideas which lead to rapid 
progression and development in order to have 
effective treatments of diseases associated with 
drugs. 
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   88/01/32 :ﺗﺎرﻳﺦ درﻳﺎﻓﺖ
   98/2/8 :ﺗﺎرﻳﺦ ﭘﺬﻳﺮش
ﺑﺮرﺳﻲ ﻓﺎﻛﺘﻮرﻫﺎي ﻫﻤﺎﺗﻮﻟﻮژﻳﻚ در اﻓﺮاد واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻛﻴﺒﺎت 
  ﭘﺲ از ﻃﻲ ﻛﺮدن دوره ﺗﺮك اﻋﺘﻴﺎد( ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ)اوﭘﻴﻮﺋﻴﺪي 
  
  *ﺳﺎﻻرﻛﻮروس دﻳﻮ ،*ﻣﺤﻤﺪرﺿﺎ آﻓﺮﻳﻨﺶ، *ﻃﺎﻫﺮه ﺣﻖ ﭘﻨﺎه
  
   .، اﻳﺮانﻛﺮﻣﺎن ،ﺎنداﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﻣﺮﻛﺰ ﺗﺤﻘﻴﻘﺎت ﻋﻠﻮم اﻋﺼﺎب،  *
  
  :ﻣﻘﺪﻣﻪ
  ﭼﻜﻴﺪه
ﺛﻴﺮ ﺗﺮﻛﻴﺒﺎت اوﭘﻴﻮﺋﻴﺪي ﺄداﻧﺴﺘﻦ ﺗ. ﻣﺼﺮف ﻃﻮﻻﻧﻲ ﻣﺪت اوﭘﻴﻮﺋﻴﺪﻫﺎ اﺛﺮات ﻧﺎﻣﻄﻠﻮﺑﻲ ﺑﺮ ﻫﻤﻮﺳﺘﺎز ﺑﺪن دارد
ﺗﻮاﻧﺪ در ﺷﻨﺎﺧﺖ وﺿﻌﻴﺖ  ﺑﺮ ﭘﺎراﻣﺘﺮﻫﺎي ﻫﻤﺎﺗﻮﻟﻮژﻳﻚ ﺧﻮن در اﻓﺮاد واﺑﺴﺘﻪ و در ﺣﺎل ﺗﺮك اﻋﺘﻴﺎد ﻣﻲ
  .اﻗﻊ ﺷﻮدﻫﻤﻮﺳﺘﺎزي ﺑﺪن اﻳﻦ اﻓﺮاد ﺟﻬﺖ درﻣﺎن ﻣﻔﻴﺪ و
ﻛﺴﺎﻧﻲ ﻛﻪ ﺑﻴﺶ از دو ﺳﺎل ﻣﺼﺮف . ﻃﺮاﺣﻲ ﺷﺪ (lanoitces ssorC) ﻣﻘﻄﻌﻲ اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﺑﻪ ﺻﻮرت  :ﻫﺎ روش
ﮔﺮوه واﺑﺴﺘﻪ ﺑﻪ ﻫﺮوﺋﻴﻦ در ﻧﻈﺮ  و ﺑﻪ ﻋﻨﻮان ﮔﺮوه واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك ،ﻛﻨﻨﺪه ﻣﺪاوم ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ ﺑﻮدﻧﺪ
ﻫﺎي  ﻛﺮده ﺑﻮدﻧﺪ ﻧﻴﺰ ﺑﻪ ﻋﻨﻮان ﮔﺮوه اي ﻛﻪ دوره ﻳﻚ ﻣﺎﻫﻪ ﺗﺮك اﻋﺘﻴﺎد را ﺳﭙﺮي اﻓﺮاد واﺑﺴﺘﻪ. ﮔﺮﻓﺘﻪ ﺷﺪﻧﺪ
در اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﻓﺎﻛﺘﻮرﻫﺎي ﻫﻤﺎﺗﻮﻟﻮژي ﻣﺮﺑﻮط ﺑﻪ ﺧﻮن اﻧﺴﺎن . ﺗﺮك ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ وارد ﻣﻄﺎﻟﻌﻪ ﺷﺪﻧﺪ
  .ﻫﺮوﺋﻴﻦ و اﻓﺮاد در ﺣﺎل ﺗﺮك اﻋﺘﻴﺎد ﻣﻮرد ﺑﺮرﺳﻲ ﻗﺮار ﮔﺮﻓﺖ اﻓﺮاد واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك و
در ﮔﺮوه واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك اﻓﺰاﻳﺶ ﮔﻠﺒﻮل ﺳﻔﻴﺪ ﺗﻌﺪاد . ﺮ ﻣﺎﻧﺪﻫﺎ ﺑﺪون ﺗﻐﻴﻴ در ﺗﻤﺎم ﮔﺮوه ﮔﻠﺒﻮل ﻗﺮﻣﺰ ﺗﻌﺪاد  :ﻫﺎ ﻳﺎﻓﺘﻪ
داري  اﻣﺎ در اﻓﺮاد واﺑﺴﺘﻪ ﺑﻪ ﻫﺮوﺋﻴﻦ و ﮔﺮوه ﺗﺮك ﻫﺮوﺋﻴﻦ ﻣﻘﺪار آن ﺗﻐﻴﻴﺮ ﻣﻌﻨﻲ ،داري ﻧﺸﺎن داد ﻣﻌﻨﻲ
درﺻﺪ . دار ﻧﺸﺎن داد ﻫﺎي ﺗﺮك ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ اﻓﺰاﻳﺶ ﻣﻌﻨﻲ ﺗﻨﻬﺎ در ﮔﺮوه ﻫﻤﻮﮔﻠﻮﺑﻴﻦ ﺳﻄﺢ. ﻧﺸﺎن ﻧﺪاد
ﻫﺎي واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك و  در ﮔﺮوه VCMﻣﻴﺰان . ﻓﺖﻳﺎداري  ﻫﺎ اﻓﺰاﻳﺶ ﻣﻌﻨﻲ ﺎم ﮔﺮوهدر ﺗﻤ ﻫﻤﺎﺗﻮﻛﺮﻳﺖ
دار  ﻫﺎي ﺗﺮك ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ اﻓﺰاﻳﺶ ﻣﻌﻨﻲ در ﮔﺮوه HCMﻣﻴﺰان . واﺑﺴﺘﻪ ﺑﻪ ﻫﺮوﺋﻴﻦ اﻓﺰاﻳﺶ ﻳﺎﻓﺖ
ﺗﻌﺪاد . دار ﻧﺸﺎن داد ﻫﺎي واﺑﺴﺘﻪ و ﺗﺮك اوﭘﻴﻮﺋﻴﺪﻫﺎ اﻓﺰاﻳﺶ ﻣﻌﻨﻲ در ﺗﻤﺎم ﮔﺮوه CHCMﻣﻴﺰان . داﺷﺖ
ﺗﻌﺪاد ﭘﻼﻛﺖ، ﻧﻮﺗﺮوﻓﻴﻞ و . ﻳﺎﺑﺪ داري ﻣﻲ در اﻓﺮاد واﺑﺴﺘﻪ دو ﮔﺮوه ﻛﺎﻫﺶ ﻣﻌﻨﻲ ﻟﻨﻔﻮﺳﻴﺖو ﻧﻮﺗﺮوﻓﻴﻞ 
در اﻓﺮاد ﮔﺮوه ﺗﺮك  ﻣﻨﻮﺳﻴﺖ ﺗﻌﺪاد. ﻳﺎﺑﺪ داري در اﻓﺮاد واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك اﻓﺰاﻳﺶ ﻣﻲ ﻣﻨﻮﺳﻴﺖ ﺑﻪ ﻃﻮر ﻣﻌﻨﻲ
  .ﻣﺎﻧﺪﻐﻴﻴﺮ ﻫﺎ ﺑﺪون ﺗ در ﺗﻤﺎم ﮔﺮوهاﺋﻮزﻳﻨﻮﻓﻴﻞ ﺗﻌﺪاد . ﻳﺎﺑﺪ دار ﻣﻲ ﻫﺮوﺋﻴﻦ ﻛﺎﻫﺶ ﻣﻌﻨﻲ
اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﻣﺸﺨﺺ ﻧﻤﻮد ﻛﻪ ﻧﻪ ﺗﻨﻬﺎ ﻣﺼﺮف ﻃﻮﻻﻧﻲ ﻣﺪت ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ، ﺑﻠﻜﻪ ﺗﺮك اﻋﺘﻴﺎد در اﻓﺮاد   :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
  .دﻫﺪﺗﻮاﻧﺪ ﻓﺎﻛﺘﻮرﻫﺎي ﻫﻤﺎﺗﻮﻟﻮژي ﻣﺮﺑﻮط ﺑﻪ ﺳﺮم اﻧﺴﺎن را ﺗﻐﻴﻴﺮ  واﺑﺴﺘﻪ ﺑﻪ ﺗﺮﻳﺎك و ﻫﺮوﺋﻴﻦ ﻣﻲ
  .ﻋﺘﻴﺎد، ﺗﺮﻳﺎك، ﻫﺮوﺋﻴﻦ، اﻳﺮانﻓﺎﻛﺘﻮرﻫﺎي ﻫﻤﺎﺗﻮﻟﻮژي، ﺳﺮم، اﻋﺘﻴﺎد، ﺗﺮك ا  :واژﮔﺎن ﻛﻠﻴﺪي
  :ﺗﻌﺪاد ﺻﻔﺤﺎت
  :ﻫﺎ ﺗﻌﺪاد ﺟﺪول
  :ﺗﻌﺪاد ﻧﻤﻮدارﻫﺎ
  :ﺗﻌﺪاد ﻣﻨﺎﺑﻊ
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  .ﻳﺮانا، ﻛﺮﻣﺎن، داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎن ،، ﭘﮋوﻫﺸﮕﺮ ﻋﻠﻮم اﻋﺼﺎبﻛﺎرﺷﻨﺎس ارﺷﺪ ﻋﺮﻓﺎن اﺳﻼﻣﻲ ،ﻛﻮروس دﻳﻮﺳﺎﻻر  :ولﺆﻣﺴ هآدرس ﻧﻮﻳﺴﻨﺪ
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